Controlled Drugs Sample Clauses

Controlled Drugs. 1.2 Explosives
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
Controlled Drugs. RXTPL reserves the right to refuse to ship to any Customer all or part of any order containing controlled substances regulated by the U.S. Drug Enforcement Administration or “drug of concern” designated by RXTPL if such order does not comply with RXTPL's Registrant Verification protocol, Suspicious Order Monitoring System or any other due diligence requirement imposed by RXTPL. RXTPL shall report any suspicious orders for controlled substances placed by any Customer in accordance with federal law. The Client shall pay RXTPL in accordance with Exhibit A for all time expended plus costs actually incurred by RXTPL in the performance of extraordinary Due Diligence services. Such services include, but are not limited to, the following: site visits to a Customer location when RXTPL determines such a visit is a required aspect of due diligence, enhanced or unusual data collection or review services, compliance training or consultation provided to the Client or any Customer, and any other due diligence, compliance or regulatory services RXTPL is required to perform in order to comply with laws applicable to the Client’s sales to any Customer. The Client shall at all times remain solely responsible for ensuring that all orders placed by any Customer comply with the Laws in the Territory, and will defend and indemnify RXTPL against any and all claims including claims or administrative actions by the Drug Enforcement Administration, the U.S. Department of Justice, the U.S. Food and Drug Administration or any other federal, state or local regulatory agency, arising from the sale or attempted sale by the Client of any Product to any Customer.
Sample 1Sample 2
Controlled Drugs. Where any pupil is prescribed controlled drugs which are needed in school such arrangements will be detailed in an Individual Healthcare Plan. The plan is to set out the training, security and supervision arrangements required. A lockable cabinet satisfying the requirements of the Misuse of Drugs Act is provided in the Welfare Hub. The Headmaster is to maintain a list of those members of staff authorised to draw keys. Invasive Techniques or regular Intimate Care Where an individual’s condition would require staff to perform any invasive technique or which is likely to require routine intimate care, this is to be fully detailed in an Individual Healthcare Plan. Appropriate training is to be provided to the staff by the School Nursing Service.
Sample 1
Controlled Drugs. Has medication on the MAR been identified as a controlled drug? Yes No If yes, has the medication been added to the CD book or Countdown sheet? Yes No Reassessment and Customer consent to service Date Name of person completing reassessment/agreement Signature of Customer
Sample 1
Controlled Drugs. Controlled drugs are those drugs classified under the ‘Misuse of Drugs Act 1971’, and its associated regulations.
Sample 1

Related to Controlled Drugs

  • Controlled Substances Has current controlled substances registrations issued by the State of Colorado and the U.S. Drug Enforcement Administration, which registrations have not been surrendered, suspended, revoked or restricted in any manner;

  • Controlled Entities The principal subsidiaries listed on Exhibit 21.1 of the Registration Statement shall be referred to hereinafter each as a “Controlled Entity” and collectively as “Controlled Entities.” To the Company’s knowledge, each Controlled Entity has been duly organized and is validly existing under the laws of the jurisdiction of its organization (to the extent such concept exists in such jurisdiction), with power and authority (corporate and other) to own its properties and conduct its business as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus; and, to the extent applicable, each Controlled Entity is duly qualified to do business as a foreign corporation in all other jurisdictions in which its ownership or lease of property or the conduct of its business requires such qualification, except to the extent that the failure to be so qualified or be in good standing would not be reasonably likely to result in any Material Adverse Change; the constitutive documents of each Controlled Entity comply with the requirements of applicable laws of the jurisdiction of its organization and are in full force and effect. Except as may not be required by applicable law, all of the issued and outstanding share capital of each Controlled Entity has been duly authorized and validly issued and is fully paid (to the extent such concept exists or is applicable in such jurisdiction), and such share capital is owned, directly or indirectly, by the Company as set forth in the Registration Statement, the Pricing Disclosure Package and Prospectus, free from liens, encumbrances and claims, except to the extent that such liens, encumbrances or claims would not result in a Material Adverse Change. Except as disclosed in the Registration Statement, the Pricing Disclosure and the Prospectus, (i) no Controlled Entities is currently prohibited, directly or indirectly, from paying any dividends to the Company (or the Company’s subsidiary that holds the outstanding equity interest of such Controlled Entity); and (ii) no Controlled Entity is prohibited, directly or indirectly, from making any other distribution on such Controlled Entity’s equity capital, from repaying to the Company any loans or advances to such Controlled Entity from the Company or any of the Company’s subsidiaries. To the Company’s knowledge, none of the Controlled Entities or any of their properties, assets or revenues are entitled to any right of immunity on the grounds of sovereignty from any legal action, suit or proceeding, from set-off or counterclaim, from the jurisdiction of any court, from services of process, from attachment prior to or in aid of execution of judgment, or from any other legal process or proceeding for the giving of any relief or for the enforcement of any judgment.

  • Controlled Foreign Corporation The Company will provide written notice to the Investors as soon as practicable if at any time the Company becomes aware that it or any Group Company has become a “controlled foreign corporation” (“CFC”) within the meaning of Xxxxxxx 000 xx xxx Xxxxxx Xxxxxx Internal Revenue Code of 1986 (the “Code”). Upon written request of any Investor who is a United States shareholder within the meaning of Section 951(b) of the Code, the Company will (i) use reasonable best efforts to provide in writing such information as is in its possession and reasonably available concerning its shareholders to assist such Investor in determining whether the Company is a CFC and (ii) provide such Investor with reasonable access to such other Company information as is in the Company’s possession and reasonably available as may be required by such Investor (A) to determine the Company’s status as a CFC, (B) to determine whether such Investor is required to report its pro rata portion of the Company’s “Subpart F income” (as defined in Section 952 of the Code) on its United States federal income tax return, or (C) to allow such Investor to otherwise comply with applicable United States federal income tax laws; provided that the Company may require such Investor to enter into a confidentiality agreement in customary form.

  • Health and Welfare Benefit Plans During the Employment Period, Executive and Executive’s immediate family shall be entitled to participate in such health and welfare benefit plans as the Employer shall maintain from time to time for the benefit of senior executive officers of the Employer and their families, on the terms and subject to the conditions set forth in such plan. Nothing in this Section shall limit the Employer’s right to change or modify or terminate any benefit plan or program as it sees fit from time to time in the normal course of business so long as it does so for all senior executives of the Employer.

  • Health and Welfare Plans (a) A copy of the master contracts with the carriers for the extended health care, dental and group life plans shall be sent to the President of the Union.

  • Foreign Plans 24 8.2 EFFECT IF DISTRIBUTION DOES NOT OCCUR..................................................24 8.3

  • Not Plan Assets; No Prohibited Transactions None of the assets of the Borrower, any other Loan Party or any other Subsidiary constitutes “plan assets” within the meaning of ERISA, the Internal Revenue Code and the respective regulations promulgated thereunder. Assuming that no Lender funds any amount payable by it hereunder with “plan assets,” as that term is defined in 29 C.F.R. 2510.3-101, the execution, delivery and performance of this Agreement and the other Loan Documents, and the extensions of credit and repayment of amounts hereunder, do not and will not constitute “prohibited transactions” under ERISA or the Internal Revenue Code.

  • Controlled Group All trades or businesses (whether or not incorporated) under common control that, together with the Borrower, are treated as a single employer under Section 414(b) or 414(c) of the Code or Section 4001 of ERISA.

  • Prescription Claims against the Issuer or any Guarantor for the payment of principal or Additional Amounts, if any, on the Notes will be prescribed ten years after the applicable due date for payment thereof. Claims against the Issuer or any Guarantor for the payment of interest on the Notes will be prescribed five years after the applicable due date for payment of interest.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!